Allarity Therapeutics, Inc. Interest Income (Expense), Net
Allarity Therapeutics, Inc. (ALLR) reported Interest Income (Expense), Net of -$1.35 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-13.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2023-03-13
- Allarity Therapeutics, Inc. interest income (expense), net for the quarter ending 2021-09-30 was $28.00K, a 87.33% decline year-over-year.
- Allarity Therapeutics, Inc. interest income (expense), net for the quarter ending 2021-06-30 was -$393.00K.
- Allarity Therapeutics, Inc. interest income (expense), net for the quarter ending 2021-03-31 was -$87.00K.
- Allarity Therapeutics, Inc. interest income (expense), net for the quarter ending 2020-09-30 was $221.00K.
- Allarity Therapeutics, Inc. interest income (expense), net for fiscal 2021 was -$1.35M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 3 month as first filed | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | -$1.35M 10-K · filed 2023-03-13 | ||||
| 2021-09-30 | $28.00K 10-Q/A · filed 2022-05-17 | -$28.00K 10-Q · filed 2021-11-23 | -$365.00K derived: sum of 2 quarters · filed 2022-10-07 | -$452.00K derived: sum of 3 quarters · filed 2022-10-07 | |
| 2021-06-30 | -$393.00K 10-Q · filed 2022-10-07 | -$480.00K 10-Q · filed 2022-10-07 | |||
| 2021-03-31 | -$87.00K 10-Q · filed 2022-05-27 | ||||
| 2020-09-30 | $221.00K 10-Q/A · filed 2022-05-17 | -$221.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |